Skip to main content
Equibles

Allianz Asset Management GmbH

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1535323 MUNICH, 2M
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$18,850,990
+$18,346,828 QoQ
Shares Held
231,102
+3023.0% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#65
of 383 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $783,743,061 across 80 Biotechnology names. PTCT ranks #10 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 380,618 $237,330,545
2 JAZZ
Jazz Pharmaceuticals plc
 545,071 $131,345,757
3 MRNA
Moderna, Inc.
 984,497 $68,944,324
4 EXEL
Exelixis, Inc.
 666,268 $36,251,640
5 INCY
Incyte Corp
 229,921 $26,063,844
6 BMRN
Biomarin Pharmaceutical Inc
 418,602 $23,952,406
7 APGE
Apogee Therapeutics, Inc.
 177,000 $23,493,210
8 FTRE
Fortrea Holdings Inc.
 1,141,537 $19,862,743

All Filings in PTCT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,850,990 231,102
2026-03-31 $504,162 7,400
2025-12-31 $1,107,876 14,585
2025-09-30 $509,371 8,300
2025-06-30 $371,184 7,600
2025-03-31 $657,384 12,900
2024-12-31 $794,464 17,600
2022-06-30 $740,909 18,495
2022-03-31 $2,674,194 71,675
2021-12-31 $2,854,815 71,675
2021-03-31 $1,079,580 22,800
2020-12-31 $1,395,206 22,861
2020-09-30 $1,091,752 23,353
2020-06-30 $2,498,539 49,242
2020-03-31 $3,430,598 76,902